To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
Specifications
- Assay Type:Sandwich
- Conjugate ELISA:HRP
- Host:
- Primary antibody reactivity:Mouse
- Target protein:Periostin
- Description:Periostin (OSF2) Mouse ELISA
- Size:96 wells (1 kit)
- Environmentally Preferable:
- Sample Type:Cell culture supernatant, plasma, serum
- Detection Range:3–2000 pg/ml
- Sensitivity:10 pg/ml
- Regulatory Status:RUO
- Cat. No.:101076-608
- Supplier no.:RAG020R
Specifications
About this item
Periostin is thought to be involved in osteoblast recruitment, attachment and spreading.
- Calibration Range: 3–2000 pg/mL
- Limit of Detection: 10 pg/mL
- Cell culture supernatant, Plasma, Serum: sample diluiton will need to be determined, start at 4000 to 8000x
Periostin was originally isolated as an osteoblast-specific factor that functions as a cell adhesion molecule for pre-osteoblasts and is thought to be involved in osteoblast recruitment, attachment and spreading. Additionally, periostin expression has previously been shown to be significantly increased by both transforming growth factor β1 (TGF-β1) and bone morphogenetic protein 2 (BMP-2). Abnormal expression of periostin is also linked to angiogenesis and metastasis in epithelial tumors. Periostin up-regulation in cancers usually correlates with aggressiveness and/or poor survival.